Concept Life Sciences has taken two new lab spaces at Alderley Park, adding 55 scientists to sustain its 30% year-over-year growth momentum.
Looking to boost its drug offerings, U.K. CRO Clinigen has paid £150.3 million (around $200 million) to buy out Quantum Pharma.
RBM is, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site- and patient-centric environment.
Biopharma intelligence firm Ozmosi has launched a database that aims to include almost all clinical trials around the world.
Antidote, which develops an online platform to match patients with researchers, just raised $11 million backed by Merck's GHI fund.
Greenphire integrates its patient payment solution into mProve's patient engagement mobile app.
Parexel has set up a team committed to providing real-world data insights.
Machine learning-focused software company Teckro has raised $10 million in series B financing to advance its clinical trial digital platform.
A nonprofit CRO formed by several ex-DuPont scientists will start operating at a new lab on Oct.1.
Parexel says it has delivered revenue “beyond expectation” in one of its last financials before being merged into Pamplona Capital Management.
Dutch virology CRO Viroclinics plans to expand its service offerings as it was acquired by private equity firm Parcom Capital.